ClinicalTrials.govpublic full text
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab
non-small cell lung cancer, advanced solid tumors, gastroesophageal adenocarcinoma, colorectal cancer, abbv-400, met amplification, met mutation, trifluridine/tipiracil, tas-102, bevacizumab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968292
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.